Wall Street analyst estimates for Neogen Corporation (NEOG): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 11 |
| Avg rating (1-5) | 0.36 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-10-06 | $0.05 | ||
| 2026-07-30 | $0.09 | $0.06 | +58.8% |
| 2026-04-09 | $0.09 | $0.04 | +125.0% |
| 2026-01-08 | $0.10 | $0.07 | +42.9% |
| 2025-10-09 | $0.04 | $-0.07 | +154.1% |
| 2025-07-28 | $-2.82 | $0.08 | -3625.0% |
| 2025-04-09 | $-0.05 | $0.13 | -138.5% |
| 2025-01-10 | $-2.10 | $0.09 | -2433.3% |
Valuation Ratios
| Price / Book | 1.26 |
| EV / EBITDA | 19.27 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $358.3M | $397.9M | $414.2M | $418.2M | $468.5M | $527.2M | $822.4M | $924.2M | $894.7M | $870.4M |
| Cost of Revenue | $189.4M | $211.7M | $222.3M | $221.9M | $253.4M | $284.1M | $416.5M | $461.6M | $473.3M | $461.9M |
| Gross Profit | $168.9M | $186.3M | $191.9M | $196.3M | $215.1M | $243.0M | $406.0M | $462.6M | $421.4M | $408.5M |
| Research & Development | $10.4M | $10.9M | $12.8M | $14.8M | $16.2M | $17.0M | $26.0M | $22.5M | $21.1M | $18.4M |
| Selling, General & Admin | $93.6M | $105.2M | $111.0M | $114.0M | $124.6M | $167.3M | $342.4M | $382.8M | $402.0M | $411.7M |
| Operating Expenses | $104.0M | $116.1M | $123.8M | $128.8M | $140.9M | $184.4M | $368.4M | $385.2M | $412.0M | $430.1M |
| Operating Income | $64.9M | $70.2M | $68.1M | $67.5M | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M | -$21.6M |
| EBITDA | $81.4M | $90.5M | $90.6M | $90.7M | $96.3M | $83.9M | $122.3M | $182.6M | -$937.8M | $170.5M |
| Interest Expense | 0 | 0 | 0 | 0 | $78,000 | $72,000 | $56.0M | $73.4M | $71.6M | $57.6M |
| Pre-tax Income | $66.7M | $73.5M | $73.0M | $72.3M | $75.3M | $60.2M | -$22.0M | -$14.3M | -$1.13B | -$9.0M |
| Income Tax | $22.7M | $10.2M | $12.8M | $12.8M | $14.4M | $11.9M | $828,000 | -$4.9M | -$41.1M | -$1.1M |
| Net Income | $43.8M | $63.1M | $60.2M | $59.5M | $60.9M | $48.3M | -$22.9M | -$9.4M | -$1.09B | -$7.9M |
| EPS | $0.43 | $0.61 | $0.58 | $0.57 | $0.57 | $0.45 | $-0.12 | $-0.04 | $-5.03 | $-0.04 |
| EPS (Diluted) | $0.43 | $0.60 | $0.57 | $0.56 | $0.57 | $0.45 | $-0.12 | $-0.04 | $-5.03 | $-0.04 |
| Shares Outstanding (Diluted) | $102.3M | $104.4M | $104.8M | $105.7M | $107.1M | $108.0M | $188.9M | $216.5M | $216.9M | $217.5M |
Price
| Price | $13.01 |
| Market Cap | $2.8B |
| Exchange | NASDAQ |
| Country | US |
Related companies: AZTA · BLFS · CNMD · KMTS · NTLA · NVCR · OPK
Explore sector: Healthcare · Medical - Devices
More sections of NEOG: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks